Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy

AIM: To observe the comparison of vitrectomy combined drug therapy(Ranibizumab injection)and single vitrectomy for proliferatived diabetic retinopathy(PDR)and the influence of the curative effect and prognosis of patients. <p>METHODS: In this study, 112 cases(125 eyes)with PDR were selected an...

Full description

Bibliographic Details
Main Authors: Xue-Qun Yu, Guo-Ping Cao, Ming-Xia Tang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2015-08-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2015/8/201508025.pdf
id doaj-c3869ff91f494125bf38dce5f338477f
record_format Article
spelling doaj-c3869ff91f494125bf38dce5f338477f2020-11-24T22:47:54ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232015-08-011581402140410.3980/j.issn.1672-5123.2015.8.25Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathyXue-Qun Yu0Guo-Ping Cao1Ming-Xia Tang2Department of Ophthalmology, Taizhou People's Hospital, Taizhou 225300, Jiangsu Province, ChinaDepartment of Ophthalmology, Taizhou People's Hospital, Taizhou 225300, Jiangsu Province, ChinaDepartment of Ophthalmology, Taizhou People's Hospital, Taizhou 225300, Jiangsu Province, ChinaAIM: To observe the comparison of vitrectomy combined drug therapy(Ranibizumab injection)and single vitrectomy for proliferatived diabetic retinopathy(PDR)and the influence of the curative effect and prognosis of patients. <p>METHODS: In this study, 112 cases(125 eyes)with PDR were selected and randomly divided into experimental group and control group(<i>n</i>=56). Fifty-six cases(61 eyes)in experimental group were injected by drug therapy of 0.5mg ranibizumab and received vitrectomy; In control group, 56 cases(64 eyes)were received single vitrectomy. The intraoperative and postoperative differences of clinical indicators were analyzed in two groups. <p>RESULTS: The average operation time, intraoperative electric coagulation hemostasis rate and iatrogenic hiatal incidence of the experimental group were lower than that of the control group:(95.00±13.00)min <i>vs</i>(133.00±14.5)min, 11% <i>vs</i> 34%, 5% <i>vs</i> 20%, respectively(<i>P</i><0.05). The anterior chamber and vitreous body cavity hemorrhage rate within postoperative 1mo in the experimental group were lower than that of the control group: 7% <i>vs</i> 23%, 5% <i>vs</i> 12%, respectively(<i>P</i><0.05). The postoperative visual acuity of experimental group was better than that of the control group: 0.375±0.210 <i>vs </i>0.261±0.170, respectively(<i>P</i><0.05). <p>CONCLUSION: Patients with PDR injected with ranibizumab in vitreous cavity before vitrectomy can effectively reduce the operation time, less intraoperative blood loss, the incidence of iatrogenic hiatus, and intraoperative and postoperative complications. The postoperative visual acuity was better than before.http://ies.ijo.cn/cn_publish/2015/8/201508025.pdfvitrectomyproliferatived diabetic retinopathyranibizumab
collection DOAJ
language English
format Article
sources DOAJ
author Xue-Qun Yu
Guo-Ping Cao
Ming-Xia Tang
spellingShingle Xue-Qun Yu
Guo-Ping Cao
Ming-Xia Tang
Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
Guoji Yanke Zazhi
vitrectomy
proliferatived diabetic retinopathy
ranibizumab
author_facet Xue-Qun Yu
Guo-Ping Cao
Ming-Xia Tang
author_sort Xue-Qun Yu
title Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
title_short Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
title_full Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
title_fullStr Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
title_full_unstemmed Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
title_sort effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy
publisher Press of International Journal of Ophthalmology (IJO PRESS)
series Guoji Yanke Zazhi
issn 1672-5123
1672-5123
publishDate 2015-08-01
description AIM: To observe the comparison of vitrectomy combined drug therapy(Ranibizumab injection)and single vitrectomy for proliferatived diabetic retinopathy(PDR)and the influence of the curative effect and prognosis of patients. <p>METHODS: In this study, 112 cases(125 eyes)with PDR were selected and randomly divided into experimental group and control group(<i>n</i>=56). Fifty-six cases(61 eyes)in experimental group were injected by drug therapy of 0.5mg ranibizumab and received vitrectomy; In control group, 56 cases(64 eyes)were received single vitrectomy. The intraoperative and postoperative differences of clinical indicators were analyzed in two groups. <p>RESULTS: The average operation time, intraoperative electric coagulation hemostasis rate and iatrogenic hiatal incidence of the experimental group were lower than that of the control group:(95.00±13.00)min <i>vs</i>(133.00±14.5)min, 11% <i>vs</i> 34%, 5% <i>vs</i> 20%, respectively(<i>P</i><0.05). The anterior chamber and vitreous body cavity hemorrhage rate within postoperative 1mo in the experimental group were lower than that of the control group: 7% <i>vs</i> 23%, 5% <i>vs</i> 12%, respectively(<i>P</i><0.05). The postoperative visual acuity of experimental group was better than that of the control group: 0.375±0.210 <i>vs </i>0.261±0.170, respectively(<i>P</i><0.05). <p>CONCLUSION: Patients with PDR injected with ranibizumab in vitreous cavity before vitrectomy can effectively reduce the operation time, less intraoperative blood loss, the incidence of iatrogenic hiatus, and intraoperative and postoperative complications. The postoperative visual acuity was better than before.
topic vitrectomy
proliferatived diabetic retinopathy
ranibizumab
url http://ies.ijo.cn/cn_publish/2015/8/201508025.pdf
work_keys_str_mv AT xuequnyu effectofvitrectomycombinedmedicationhyperplasticonpatientswithdiabeticretinopathy
AT guopingcao effectofvitrectomycombinedmedicationhyperplasticonpatientswithdiabeticretinopathy
AT mingxiatang effectofvitrectomycombinedmedicationhyperplasticonpatientswithdiabeticretinopathy
_version_ 1725680625277468672